Mastek stock has corrected ~7% and 23% in the last one and three months, respectively, and is trading at a P/E of 18x and 15x FY26/27E EPS. (Photo Source: pexels)
With a budget of ~£200 billion, NHS England is a major client for Mastek, contributing ~22% of its revenue. Mastek's management is closely monitoring these changes but does not anticipate a major impact on spending. However, there may be short-term uncertainty and delays due to the merger activities.